Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Cash: 2010-2025

Historic Change in Cash for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to $4.8 million.

  • Anika Therapeutics' Change in Cash rose 1162.33% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year increase of 47.14%. This contributed to the annual value of -$15.7 million for FY2024, which is 16.70% down from last year.
  • Per Anika Therapeutics' latest filing, its Change in Cash stood at $4.8 million for Q3 2025, which was up 2,464.22% from -$204,000 recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Change in Cash peaked at $5.6 million during Q3 2023, and registered a low of -$14.7 million during Q2 2023.
  • For the 3-year period, Anika Therapeutics' Change in Cash averaged around -$2.6 million, with its median value being -$3.8 million (2025).
  • Per our database at Business Quant, Anika Therapeutics' Change in Cash plummeted by 1,474.51% in 2023 and then soared by 1,162.33% in 2025.
  • Anika Therapeutics' Change in Cash (Quarterly) stood at $3.4 million in 2021, then crashed by 142.52% to -$1.4 million in 2022, then soared by 252.83% to $2.2 million in 2023, then plummeted by 335.06% to -$5.2 million in 2024, then soared by 1,162.33% to $4.8 million in 2025.
  • Its Change in Cash was $4.8 million in Q3 2025, compared to -$204,000 in Q2 2025 and -$3.8 million in Q1 2025.